RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsJust sayin ... US$12-15 Bln for ONCY is certainly in play now that the FTC has decided against the Amgen/Horizon US$28 Bln acquistion for reasons already provided. The FTC's decision points to the unlikelihood of Pfizer/Seagen US$43 Bln proposed acquisition from being completed, again for reasons provided.